Angioneurotic Edema Completed Phase 2 / 3 Trials for Conestat alfa (DB09228)
Also known as: Angioneurotic oedema / Allergic angioedema / Allergic angioedema (disorder) / Angioedema (morphologic abnormality) / Oedema angioneurotic / Quincke's edema / Angioedema / Angioedema (disorder) / Angioedemas / Edema angioneurotic / Angioedema and urticaria / Angio-edema / Oedema Quincke's / Quincke's oedema / Giant urticaria / Edema Quincke's / Urticaria giant / Giant urticaria (disorder) / Giant hives / Hives giant
Indication | Status | Phase |
---|---|---|
DBCOND0031400 (Angioneurotic Edema) | Completed | 2 / 3 |
clinicaltrials.gov Identifier | Title | Purpose | Drugs |
---|---|---|---|
NCT00225147 | Recombinant Human C1 Inhibitor for the Treatment of Acute Attacks in Patients With Hereditary Angioedema | Treatment |